1. Home
  2. FELE vs COGT Comparison

FELE vs COGT Comparison

Compare FELE & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Electric Co. Inc.

FELE

Franklin Electric Co. Inc.

HOLD

Current Price

$96.71

Market Cap

4.6B

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

SELL

Current Price

$30.01

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FELE
COGT
Founded
1944
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.5B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
FELE
COGT
Price
$96.71
$30.01
Analyst Decision
Buy
Strong Buy
Analyst Count
5
12
Target Price
★ $118.50
$55.82
AVG Volume (30 Days)
229.9K
★ 2.0M
Earning Date
10-27-2026
11-02-2026
Dividend Yield
★ 1.16%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.77
N/A
Revenue
★ $2,131,250,000.00
$7,871,000.00
Revenue This Year
$6.41
N/A
Revenue Next Year
$5.72
$4,789.59
P/E Ratio
$125.81
★ N/A
Revenue Growth
★ 5.44
N/A
52 Week Low
$89.54
$13.79
52 Week High
$115.82
$43.73

Technical Indicators

Market Signals
Indicator
FELE
COGT
Relative Strength Index (RSI) 44.29 31.60
Support Level $95.08 N/A
Resistance Level $102.40 $37.69
Average True Range (ATR) 1.76 1.31
MACD 0.42 -0.03
Stochastic Oscillator 39.85 29.39

Price Performance

Historical Comparison
FELE
COGT

About FELE Franklin Electric Co. Inc.

Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: